Selected News & Events
Stealth BioTherapeutics Awarded Grant from Friedreich’s Ataxia Research Alliance to Develop Investigational Mitochondrial Therapeutic SBT-589 for Friedreich’s Ataxia
Stealth BioTherapeutics Announces FDA Advisory Committee Meeting to Review Elamipretide for Barth Syndrome Treatment
Stealth BioTherapeutics Completes Mid-Cycle Review Meeting on Elamipretide for the Treatment of Barth Syndrome
Stealth BioTherapeutics Announces First Patient Enrolled in Global Phase 3 Clinical Program for Elamipretide in Patients with Dry Age-Related Macular Degeneration
Events Calendar
No events listed at this time.
Contact Us
Stealth BioTherapeutics
275 Grove Street, Suite 3-107
Newton, MA 02466
(617) 600-6888
info@stealthbt.com